title: Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
abstract: The pancreas releases insulin in a pulsatile manner; however, studies assessing the liver's response to insulin have used constant infusion rates. Our aims were to determine whether the secretion pattern of insulin [continuous (CON) vs. pulsatile] in the presence of hyperglycemia 1) influences net hepatic glucose uptake (NHGU) and 2) entrains NHGU. Chronically catheterized conscious dogs fasted for 42 h received infusions including peripheral somatostatin, portal insulin (0.25 mU x kg(-1) x min(-1)), peripheral glucagon (0.9 ng x kg(-1) x min(-1)), and peripheral glucose at a rate double the glucose load to the liver. After the basal period, insulin was infused for 210 min at either four times the basal rate (1 mU x kg(-1) x min(-1)) or an identical amount in pulses of 1 and 4 min duration, followed by intervals of 11 and 8 min (CON, 1/11, and 4/8, respectively) in which insulin was not infused. A variable peripheral glucose infusion containing [3H]glucose clamped glucose levels at twice the basal level ( approximately 200 mg/dl) throughout each study. Hepatic metabolism was assessed by combining tracer and arteriovenous difference techniques. Arterial plasma insulin (microU/ml) either increased from basal levels of 6 +/- 1 to a constant level of 22 +/- 4 in CON or oscillated from 5 +/- 1 to 416 +/- 79 and from 6 +/- 1 to 123 +/- 43 in 1/11 and 4/8, respectively. NHGU (-0.8 +/- 0.3, 0.4 +/- 0.2, and -0.9 +/- 0.4 mg x kg(-1) x min(-1)) and net hepatic fractional extraction of glucose (0.04 +/- 0.01, 0.04 +/- 0.01, and 0.05 +/- 0.01 mg x kg(-1) x min(-1)) were similar during the experimental period. Spectral analysis was performed to assess whether a correlation existed between the insulin secretion pattern and NHGU. NHGU was not augmented by pulsatile insulin delivery, and there is no evidence of entrainment in hepatic glucose metabolism. Thus the loss of insulin pulsatility per se likely has little or no impact on the effectiveness of insulin in regulating liver glucose uptake.
authors.affiliation: Dept. of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, 702 Light Hall, Nashville, TN 37232-0615, USA.
authors.forename: Jaime M
authors.initials: JM
authors.lastname: Grubert
authors.forename: Margaret
authors.initials: M
authors.lastname: Lautz
authors.forename: D Brooks
authors.initials: DB
authors.lastname: Lacy
authors.forename: Mary C
authors.initials: MC
authors.lastname: Moore
authors.forename: Ben
authors.initials: B
authors.lastname: Farmer
authors.forename: Angelina
authors.initials: A
authors.lastname: Penaloza
authors.forename: Alan D
authors.initials: AD
authors.lastname: Cherrington
authors.forename: Owen P
authors.initials: OP
authors.lastname: McGuinness
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D004285:Dogs; D004334:Drug Administration Schedule; D005947:Glucose / Q000493:pharmacokinetics*; D006943:Hyperglycemia / Q000097:blood*; D007328:Insulin / Q000008:administration & dosage / Q000097:blood*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D010507:Periodicity; D013223:Statistics as Topic
chemical_list: D001786:Blood Glucose; D007328:Insulin; D005947:Glucose